These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12846983)

  • 1. Cellular models to study dopaminergic injury responses.
    Collier TJ; Steece-Collier K; McGuire S; Sortwell CE
    Ann N Y Acad Sci; 2003 Jun; 991():140-51. PubMed ID: 12846983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
    Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of neurotrophic factors in therapy of Parkinson's disease.
    Möller JC; Sautter J; Kupsch A
    J Neural Transm Suppl; 1996; 48():103-12. PubMed ID: 8988466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
    Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
    Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models.
    Inoue H; Lin L; Lee X; Shao Z; Mendes S; Snodgrass-Belt P; Sweigard H; Engber T; Pepinsky B; Yang L; Beal MF; Mi S; Isacson O
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14430-5. PubMed ID: 17726113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
    Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
    FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic factors for the treatment of Parkinson's disease.
    Chiocco MJ; Harvey BK; Wang Y; Hoffer BJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S321-8. PubMed ID: 18267258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
    Falk T; Zhang S; Sherman SJ
    Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
    Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I
    Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
    Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
    J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
    Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
    Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease.
    Friling S; Bergsland M; Kjellander S
    BMC Neurosci; 2009 Dec; 10():146. PubMed ID: 20003337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
    Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
    Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures.
    Zhang L; Fletcher-Turner A; Marchionni MA; Apparsundaram S; Lundgren KH; Yurek DM; Seroogy KB
    J Neurochem; 2004 Dec; 91(6):1358-68. PubMed ID: 15584912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Nutr Biochem; 2016 Feb; 28():140-6. PubMed ID: 26878791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death.
    Sawada H; Ibi M; Kihara T; Urushitani M; Akaike A; Shimohama S
    J Neurosci Res; 1998 Dec; 54(5):707-19. PubMed ID: 9843162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of cultured dopamine neurons from MPP(+) requires a combination of neurotrophic factors.
    Jaumotte JD; Wyrostek SL; Zigmond MJ
    Eur J Neurosci; 2016 Jul; 44(1):1691-9. PubMed ID: 27098376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.